Supplementary Data from Long-Term Follow-up of a Phase III Study of Ch14.18 (dinutuximab) + Cytokine Immunotherapy in Children with High-Risk Neuroblastoma: COG Study ANBL0032
Clinical Cancer Research(2021)
关键词
Neuroblastoma
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要